LIVE
NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

AUROPHARMA

NSEBSE
F&O
Aurobindo Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE406A01037· Scrip: 524804
ENहिन्दीગુજરાતીमराठी
₹१,४८३.२०
▲ 55.10 (+3.86%)
6/5/2026, 3:28:22 pm
NSE
₹१,४८३.२०
▲ ५५.१०
+३.८६%
BSE
₹१,४८३.४०
▲ ५५.२०
+०.००%
1,0171,1361,2541,3731,49105-0607-0108-2810-2712-2302-2004-2905-06
२४५ व्यापार दिन · 1Y कालावधी
आज
उघडणे१,४३१.००
उच्चांक१,४८९.७०
नीचांक१,४२६.१०
मागील बंद१,४२८.१०
व्हॉल्यूम२४.०७L
मूल्य₹३५४.१Cr
L: 1,426.10H: 1,489.70
52 आठवडे
नीचांक₹१,०१६.१०
उच्चांक₹१,४८९.७०
९९% 52 आठवड्यांच्या श्रेणीत
माहिती
दर्शनी मूल्य₹१
सूचीबद्ध2000-07-19
ISININE406A01037
SeriesA
BSE स्क्रिप524804

मुख्य निर्देशक

1D
+3.86%
1W
+4.26%
1M
+10.51%
3M
+30.97%
6M
+34.95%
मूल्यांकन
P/E (TTM)२९.८५
P/E (Qtr Ann.)२५.४७
P/Sales२.८५
वाढ (तिमाही)
PAT+3.50%
EPS+4.00%
नफाक्षमता
TTM EBITDA M.२०.६%
लाभांश
वाढ+166.67%
TTM EBITDA
₹5316 Cr
TTM PAT
₹2899 Cr
TTM EPS
₹४९.६९

तिमाही वित्तीय

महसूल
EBITDA
PAT
EPS
0 Cr1995 Cr3989 Cr5984 Cr7979 Cr22-1223-0323-0923-1224-0324-0624-0924-12₹8.4₹8.6₹12.8₹16.0₹15.5₹5.6₹14.0₹14.6
तिमाहीमहसूलExpensesEBITDAPBTPATEPS
2024-12-317979 Cr6938 Cr1617 Cr1198 Cr846 Cr₹14.56
2024-09-307796 Cr6725 Cr1589 Cr1207 Cr817 Cr₹14.00
2024-06-302460 Cr2079 Cr513 Cr446 Cr329 Cr₹5.62
2024-03-317580 Cr6351 Cr1597 Cr1243 Cr907 Cr₹15.51
2023-12-317352 Cr6249 Cr1688 Cr1265 Cr940 Cr₹16.04
2023-09-307219 Cr6332 Cr1492 Cr1075 Cr752 Cr₹12.83
2023-03-316473 Cr5872 Cr1081 Cr736 Cr506 Cr₹8.64
2022-12-316407 Cr5819 Cr1002 Cr681 Cr491 Cr₹8.38

शेअरहोल्डिंग नमुना

सध्याचे — 2026-03-31
51.8%प्रवर्तक
प्रवर्तक51.8%
FII15.2%
DII25.9%
सार्वजनिक48.2%
प्रवर्तक होल्डिंग ट्रेंड
51.8%24-0651.8%24-0951.8%24-1251.8%25-0351.8%25-0951.8%25-1251.8%26-03

कॉर्पोरेट कार्यवाही

एक्स-तारीखप्रकारउद्देश
2026-04-17OtherBuy Back
2025-08-08DividendInterim Dividend - Rs 4 Per Share
2024-08-26OtherAnnual General Meeting
2024-07-30OtherBuy Back
2024-02-20DividendInterim Dividend - Rs 1.50 Per Share
2023-11-20DividendInterim Dividend - Rs 3 Per Share
2023-08-22OtherAnnual General Meeting
2023-02-17DividendInterim Dividend - Rs 3 Per Share
2022-07-27OtherAnnual General Meeting
2022-06-06DividendInterim Dividend - Rs 4.50 Per Share
2022-02-18DividendInterim Dividend - Rs 1.50 Per Share
2021-11-17Dividend Interim Dividend - Rs 1.50 Per Share
2021-08-27Dividend Interim Dividend - Rs 1.50 Per Share
2021-08-20Other Annual General Meeting
2021-02-22Dividend Interim Dividend - Rs 1.50 Per Share
2020-11-23Dividend Interim Dividend - Rs 1.25 Per Share
2020-08-21Dividend Annual General Meeting/Interim Dividend - Rs 1.25 Per Share
2020-02-17Dividend Interim Dividend - Rs 1.75 Per Share
2019-11-21Dividend Interim Dividend - Rs 1.25 Per Share
2019-08-21Other Annual General Meeting

उत्पन्न विवरण

Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
5 Nov 2025NSE15K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
4 Aug 2025NSE14K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
26 May 2025NSE15K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
6 Feb 2025NSE16K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE16K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
27 May 2023NSE14K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated February 3, 2...
10 Feb 2023NSE1K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
9 Feb 2023NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, ...
3 Feb 2023NSE2K chars
Read →
Sub: Transcript of Q2FY23 earnings call.Please refer to our letter dated November 8, 2022 wherein we...
18 Nov 2022NSE51K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated November 8, 2...
14 Nov 2022NSE1K chars
Read →
Please refer to our letter dated November 8, 2022 wherein we have intimated the schedule of Investor...
12 Nov 2022NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Re...
8 Nov 2022NSE2K chars
Read →
Further to our letter dated September 6, 2022 informing about the participation in the Kotak Institu...
7 Sept 2022NSE2K chars
Read →
Please refer to our letter dated August 8, 2022 wherein we have intimated the schedule of Investors/...
19 Aug 2022NSE55K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated August 8, 202...
12 Aug 2022NSE1K chars
Read →
Please refer to our letter dated August 8, 2022 wherein we have intimated the schedule of Investors/...
11 Aug 2022NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Re...
8 Aug 2022NSE2K chars
Read →
Please refer to our letter dated May 26, 2022 wherein we have intimated the schedule of Investors/ A...
6 Jun 2022NSE50K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated May 26, 2022,...
31 May 2022NSE1K chars
Read →

किंमत इतिहास

तारीखउघडणेउच्चांकनीचांकबंदव्हॉल्यूम
2026-05-06१,४३१.००१,४८९.७०१,४२६.१०१,४८४.००२४.२१L
2026-05-05१,३७३.९०१,४३१.००१,३६७.००१,४२८.१०१८.१२L
2026-05-04१,३९८.००१,३९८.००१,३६७.१०१,३७६.००७.७८L
2026-04-30१,३९२.००१,४०४.००१,३७८.६०१,३८९.५०६.०६L
2026-04-29१,४२५.९०१,४३३.००१,३८९.३०१,३९६.८०१७.३९L
2026-04-28१,४१५.००१,४३०.००१,४१०.३०१,४२२.६०८.४८L
2026-04-27१,४१४.९०१,४३३.४०१,३८६.६०१,४१६.७०९.९८L
2026-04-24१,४३६.९०१,४४६.००१,४११.७०१,४१३.८०९.६८L
2026-04-23१,४२०.००१,४५९.५०१,४०९.१०१,४३५.४०२२.३८L
2026-04-22१,३८९.५०१,४२५.१०१,३८२.४०१,४२१.२०१७.०४L
2026-04-21१,३६८.९०१,४०१.१०१,३६७.१०१,३९१.७०१३.६३L
2026-04-20१,३९२.००१,३९२.००१,३६३.५०१,३६७.८०७.०७L
2026-04-17१,३८८.९०१,३९४.९०१,३७५.३०१,३८६.००१६.१२L
2026-04-16१,३८९.९०१,३८९.९०१,३६८.००१,३८६.५०२२.५४L
2026-04-15१,३५०.००१,३७९.२०१,३४५.८०१,३७३.९०१८.३०L
2026-04-13१,३४०.००१,३५३.००१,३३३.००१,३३९.८०१३.७८L
2026-04-10१,३४५.००१,३५५.००१,३३६.८०१,३४९.४०९.०७L
2026-04-09१,३३५.००१,३४६.७०१,३२१.६०१,३४०.४०९.३९L
2026-04-08१,३६२.७०१,३६३.००१,३१६.८०१,३३५.७०३२.५६L
2026-04-07१,३४५.००१,३५७.५०१,३१६.००१,३३०.००१५.५८L
2026-04-02१,३३५.५०१,३३८.९०१,२६६.१०१,३३३.७०१८.७०L
2026-04-01१,३३२.२०१,३५९.९०१,३२५.९०१,३४२.१०२५.९५L
2026-03-27१,३०७.८०१,३२७.००१,२९६.००१,३१४.२०१९.२४L
2026-03-25१,२९०.४०१,३३०.००१,२८२.१०१,३०७.८०१८.९२L
2026-03-24१,३०३.००१,३१०.००१,२५५.४०१,२८१.६०१७.६९L
2026-03-20१,२६२.००१,२९७.८०१,२५८.३०१,२९१.४०१३.९६L
2026-03-19१,२५५.००१,२६९.००१,२४०.००१,२४७.५०८.१७L
2026-03-18१,२७८.००१,२९०.५०१,२६५.३०१,२६९.००१७.००L
2026-03-17१,२८४.९०१,२९५.००१,२७५.१०१,२८६.००६.३५L
2026-03-16१,३०२.००१,३१४.००१,२६५.८०१,२७९.६०१४.३७L

वारंवार विचारले जाणारे प्रश्न

बद्दल

Aurobindo Pharma Limited ही हैदराबाद येथे स्थित एक भारतीय बहुराष्ट्रीय औषध कंपनी आहे, ती उच्च-गुणवत्तेची जेनेरिक आणि ब्रँडेड फार्मास्युटिकल्स, सक्रिय फार्मास्युटिकल घटक आणि बायोसिमिलर्सचे उत्पादन आणि विपणन करण्यात माहिर आहे. हे यूएस सह जागतिक स्तरावर कार्यरत आहे.

Advertisement
BOARD OF DIRECTORS
Girish Paman Vanvari
Independent Director
Savita Mahajan
Independent Director
DEPARTED
Venkat Nageswar Chalasani
Independent Director
DEPARTED
Deepali Pant Joshi
Additional Director